A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
for Crohn's Disease (CD)
Sites in Park Ridge +14 more locations
Sponsor: Takeda
Sex: All·Age: 2 - 17
Code: NCT04779320·Phase 3·Recruiting·Listed Mar 2021
Paid Clinical Trials in Illinois
Illinois has 2,847 paid clinical trials enrolling now across cities including Chicago, Peoria and Evanston. Search by condition, age, or phase to find compensated research studies accepting participants near you.
Research sites in Illinois include Northwestern Medicine, University of Chicago Medicine and Rush, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
2,519 clinical trials
Get a weekly email when new trials open in Chicago, IL.
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
for Primary Immune Thrombocytopenia (ITP)
Sites in Chicago +16 more locations
Sponsor: argenx
Sex: All·Age: 18+
Code: NCT06544499·Phase 3·Recruiting·Listed Aug 2024
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
for COPD
Sites in Chicago, Peoria +16 more locations
Sponsor: Apreo Health, Inc.
Sex: All·Age: 40 - 84
Code: NCT06891755·Recruiting·Listed Mar 2025
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
for Lymphoid Malignancies
Sites in Chicago +10 more locations
Sponsor: AVM Biotechnology Inc
Sex: All·Age: 12 - 95
Code: NCT04329728·Phase 1, Phase 2·Recruiting·Listed Apr 2020
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
for Actinic Keratosis
Sites in Rolling Meadows +19 more locations
Sponsor: Sun Pharmaceutical Industries, Inc.
Sex: All·Age: 18 - 85
Code: NCT07144852·Phase 3·Recruiting·Listed Aug 2025
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
for Focal Onset Seizures
Drug: XEN1101
Sites in Springfield +16 more locations
Sponsor: Xenon Pharmaceuticals Inc.
Sex: All·Age: 18+
Code: NCT05716100·Phase 3·Recruiting·Listed Feb 2023
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
for Non Small Cell Lung Cancer
Sites in Chicago +14 more locations
Sponsor: Tango Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06810544·Phase 1, Phase 2·Recruiting·Listed Feb 2025
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
for Actinic Keratosis
Sites in Rolling Meadows +9 more locations
Sponsor: Sun Pharmaceutical Industries, Inc.
Sex: All·Age: 18 - 85
Code: NCT07144345·Phase 3·Recruiting·Listed Aug 2025
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
for Peripheral T-Cell Lymphoma, Not Otherwise Specified
Drug: Soquelitinib
Sites in Chicago +20 more locations
Sponsor: Corvus Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT06561048·Phase 3·Recruiting·Listed Aug 2024
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
for HR+/HER2-negative Breast Cancer
Sites in Hinsdale +9 more locations
Sponsor: SynDevRx, Inc.
Sex: All·Age: 18+
Code: NCT05455619·Phase 1, Phase 2·Recruiting·Listed Jul 2022
A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)
for Phenylketonuria (PKU)
Drug: Palynziq
Sites in Chicago +11 more locations
Sponsor: BioMarin Pharmaceutical
Sex: All·Age: All ages
Code: NCT05813678·Recruiting·Listed Apr 2023
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
for Relapsed/Refractory Multiple Myeloma
Sites in Chicago +6 more locations
Sponsor: Ichnos Sciences SA
Sex: All·Age: 18+
Code: NCT05862012·Phase 1·Recruiting·Listed May 2023
A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months
for Hypochondroplasia
Drug: Vosoritide
Sites in Chicago +9 more locations
Sponsor: BioMarin Pharmaceutical
Sex: All·Age: 0 Months - 36 Months
Code: NCT07126262·Phase 2·Recruiting·Listed Aug 2025
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
for Acute Myeloid Leukemia
Drug: Revumenib
Sites in Chicago +9 more locations
Sponsor: Syndax Pharmaceuticals
Sex: All·Age: 30 Days+
Code: NCT04065399·Phase 1, Phase 2·Recruiting·Listed Aug 2019
A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
for Rheumatoid Arthritis (RA)
Sites in Chicago +9 more locations
Sponsor: Sonoma Biotherapeutics, Inc.
Sex: All·Age: 18 - 71
Code: NCT07123038·Recruiting·Listed Aug 2025
Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps
for Chronic Rhinosinusitis Without Nasal Polyps
Sites in Springfield +19 more locations
Sponsor: Optinose US Inc.
Sex: All·Age: 12 - 17
Code: NCT06850805·Phase 3·Recruiting·Listed Feb 2025
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
for Emphysema, Pulmonary
Sites in Chicago, Peoria +14 more locations
Sponsor: Pulmonx Corporation
Sex: All·Age: 40 - 80
Code: NCT06035120·Recruiting·Listed Sep 2023
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
for Advanced or Metastatic Solid Tumors
Sites in Chicago +13 more locations
Sponsor: 858 Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06395519·Phase 1, Phase 2·Recruiting·Listed May 2024
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
for Hepatocellular Cancer
Sites in Chicago +9 more locations
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT06858813·Phase 1·Recruiting·Listed Mar 2025
A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)
for Phenylketonuria (PKU)
Drug: Palynziq
Sites in Chicago +10 more locations
Sponsor: BioMarin Pharmaceutical
Sex: All·Age: All ages
Code: NCT06305234·Recruiting·Listed Mar 2024
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
for Chronic Lymphocytic Leukemia
Sites in Chicago +19 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06876649·Phase 4·Recruiting·Listed Mar 2025
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
for Chronic Lymphocytic Leukemia
Sites in Chicago +15 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06876662·Phase 4·Recruiting·Listed Mar 2025
Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF
for Heart Failure With Preserved Ejection Fraction (HFpEF
Sites in Chicago +12 more locations
Sponsor: Axon Therapies, Inc.
Sex: All·Age: 40+
Code: NCT04592445·Recruiting·Listed Oct 2020
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
for High-risk Myelodysplastic Syndrome
Sites in Chicago +10 more locations
Sponsor: Crossbow Therapeutics, Inc.
Sex: All·Age: 12+
Code: NCT06994676·Phase 1·Recruiting·Listed May 2025
The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation
for Supratentorial Hemorrhage
Sites in Chicago +17 more locations
Sponsor: Integra LifeSciences Corporation
Sex: All·Age: 18+
Code: NCT04494295·Recruiting·Listed Jul 2020
52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
for Hypogonadism, Male
Sites in Chicago +19 more locations
Sponsor: Halozyme Therapeutics
Sex: Male·Age: 12 - 17
Code: NCT06689085·Phase 3·Recruiting·Listed Nov 2024
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
for Carcinoma, Non-Small Cell Lung
Drug: Osimertinib
Sites in Urbana +8 more locations
Sponsor: Genprex, Inc.
Sex: All·Age: 18+
Code: NCT04486833·Phase 1, Phase 2·Recruiting·Listed Jul 2020
A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer
for Ovarian Cancer
Sites in Chicago, Warrenville +11 more locations
Sponsor: Compugen Ltd
Sex: Female·Age: 18+
Code: NCT06888921·Phase 1, Phase 2·Recruiting·Listed Mar 2025
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
for Myasthenia Gravis
Sites in O'Fallon +16 more locations
Sponsor: argenx
Sex: All·Age: 18+
Code: NCT06298565·Recruiting·Listed Mar 2024
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
for Advanced Solid Tumor
Sites in Chicago +20 more locations
Sponsor: Clasp Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06778863·Phase 1·Recruiting·Listed Jan 2025
A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors
for Solid Tumor, Adult
Sites in Chicago +9 more locations
Sponsor: Corbus Pharmaceuticals Inc.
Sex: All·Age: 18+
Code: NCT06265727·Phase 1, Phase 2·Recruiting·Listed Feb 2024
To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome
for Rett Syndrome
Sites in Chicago +13 more locations
Sponsor: Biomed Industries, Inc.
Sex: Female·Age: 5 - 20
Code: NCT06840496·Phase 3·Recruiting·Listed Feb 2025
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
for Epilepsy, Temporal Lobe
Sites in Chicago +15 more locations
Sponsor: Neurona Therapeutics
Sex: All·Age: 18 - 75
Code: NCT06422923·Phase 1, Phase 2·Recruiting·Listed May 2024
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
for Dravet Syndrome
Sites in Chicago +21 more locations
Sponsor: Longboard Pharmaceuticals
Sex: All·Age: 2 - 65
Code: NCT06660394·Phase 3·Recruiting·Listed Oct 2024
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
for Psoriatic Arthritis
Sites in Skokie, Willowbrook +13 more locations
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT06865105·Phase 2·Recruiting·Listed Mar 2025
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
for Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
Sites in Chicago +21 more locations
Sponsor: Servier Bio-Innovation LLC
Sex: All·Age: 18+
Code: NCT06127407·Phase 3·Recruiting·Listed Nov 2023
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
for Movement Disorders
Sites in Chicago +7 more locations
Sponsor: Abbott Medical Devices
Sex: All·Age: All ages
Code: NCT04071847·Recruiting·Listed Aug 2019
Lysosomal Acid Lipase (LAL) Deficiency Registry
for Lysosomal Acid Lipase Deficiency
Sites in Chicago +19 more locations
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All·Age: All ages
Code: NCT01633489·Recruiting·Listed Jul 2012
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
for Non Small Cell Lung Cancer
Sites in Chicago +23 more locations
Sponsor: SystImmune Inc.
Sex: All·Age: 18+
Code: NCT05983432·Phase 1·Recruiting·Listed Aug 2023
EFS of the CardioMech MVRS
for Mitral Regurgitation
Sites in Evanston +9 more locations
Sponsor: CardioMech AS
Sex: All·Age: 18+
Code: NCT04820764·Recruiting·Listed Mar 2021